Showing results (121-130 of 437) with videos related to
Sort By:
Pageof 44
Arthritis and Rheumatism|December 2, 2009
Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot studyTien-I Karleen Su, Dinesh Khanna, Daniel E Furst, et al.The Journal of Rheumatology|June 3, 2009
Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit reportAnand N Malaviya, Sanjiv Kapoor, Shriram Garg, et al.Clinical and Experimental Rheumatology|October 5, 2011
Therapeutic approach to familial Mediterranean fever: a review updateMehmet Akif Ozturk, Mehmet Kanbay, Benan Kasapoglu, et al.BMJ Open|September 28, 2014
Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocolAnna Dossing, Simon Tarp, Daniel E Furst, et al.Clinical Immunology (Orlando, Fla.)|October 22, 2011
Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosisAnagha A Divekar, Dinesh Khanna, Fereidoun Abtin, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Etiology unknown: Qualitative analysis of patient attributions of causality in sclerodermaShadi Gholizadeh, Julia H Drizin, Ingunn Hansdottir, et al.JCI Insight|May 4, 2018
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosisSuzanne Kafaja, Isela Valera, Anagha A Divekar, et al.Journal of Scleroderma and Related Disorders|June 7, 2023
Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-beingYen T Chen, Susan L Murphy, Daniel E Furst, et al.Plos One|September 12, 2015
Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological StudyAnton Wulf Christensen, Simon Tarp, Daniel E Furst, et al.Arthritis Care & Research|October 9, 2018
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE RegistryKevin L Winthrop, Kenneth Saag, Matthew D Cascino, et al.Pageof 44